SOW
PCRX icon

State of Wyoming’s Pacira BioSciences PCRX Stock Holding History

State of Wyoming’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.5K Sell
3,094
-9,204
-75% -$218K 0.01% 1487
2026
Q1 		$278K Buy
12,298
+1,143
+10% +$25.4K 0.03% 714
2025
Q4 		$289K Buy
11,155
+728
+7% +$17.3K 0.03% 730
2025
Q3 		$269K Buy
10,427
+6,177
+145% +$152K 0.03% 753
2025
Q2 		$102K Buy
+4,250
New +$107K 0.01% 1307
2025
Q1 		– Sell
-6,566
Closed -$124K – 1795
2024
Q4 		$124K Buy
6,566
+487
+8% +$8.55K 0.02% 1079
2024
Q3 		$91.5K Buy
6,079
+634
+12% +$10.8K 0.01% 1216
2024
Q2 		$156K Buy
5,445
+423
+8% +$12K 0.03% 758
2024
Q1 		$147K Buy
5,022
+3,391
+208% +$104K 0.02% 778
2023
Q4 		$55K Sell
1,631
-1,638
-50% -$47.9K 0.01% 1275
2023
Q3 		$100K Buy
3,269
+2,359
+259% +$85K 0.02% 855
2023
Q2 		$36.5K Buy
910
+204
+29% +$8.43K 0.01% 1239
2023
Q1 		$28.8K Buy
706
+99
+16% +$3.94K 0.01% 1301
2022
Q4 		$23.4K Sell
607
-1,940
-76% -$94.4K 0.01% 1333
2022
Q3 		$136K Buy
2,547
+612
+32% +$34K 0.07% 414
2022
Q2 		$113K Sell
1,935
-476
-20% -$31.2K 0.07% 424
2022
Q1 		$184K Buy
2,411
+99
+4% +$6.6K 0.09% 234
2021
Q4 		$139K Buy
2,312
+209
+10% +$11.5K 0.06% 416
2021
Q3 		$118K Buy
2,103
+376
+22% +$21.7K 0.08% 362
2021
Q2 		$105K Buy
+1,727
New +$109K 0.07% 431

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's PCRX Position: Q2 2026 in Review

State of Wyoming reduced its Pacira BioSciences (PCRX) stake by 75% in Q2 2026, selling an estimated $218K and leaving 3,094 shares worth $78.5K. The position accounts for 0.01% of the portfolio, ranked #1487.

State of Wyoming first reported a position in PCRX in Q2 2021 and has held it in 20 quarters since. The position peaked at $289K in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • State of Wyoming held 3,094 shares of Pacira BioSciences worth $78.5K as of Q2 2026.
  • State of Wyoming sold 9,204 Pacira BioSciences shares in Q2 2026, an estimated $218K.
  • Pacira BioSciences made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1487 holding.
  • State of Wyoming first reported a position in Pacira BioSciences in Q2 2021 and has held it in 20 quarters since.
  • State of Wyoming's Pacira BioSciences position peaked at $289K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.